Abiopharma

C3.AI, INC. (AI)

Symbol	AI
Name	C3.AI, INC.
Sector	TECHNOLOGY
Region	North America
Industry	Computer Software: Prepackaged Software
Address	1300 SEAPORT BOULEVARD,SUITE 500, REDWOOD CITY, California, 94063, United States
Telephone	+1 650 503-2200
Fax	—
Email	—
Website	https://www.c3.ai
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001577526
Description	C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type; C3 AI Applications, include a large and growing family of industry-specific and application-specific turnkey AI solutions that can be immediately installed and deployed; and C3.ai Ex Machina, analytics for applying data science to every-day business decisions. Additional info from NASDAQ: C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type; C3 AI Applications, include a large and growing family of industry-specific and application-specific turnkey AI solutions that can be immediately installed and deployed; and C3.ai Ex Machina, analytics for applying data science to every-day business decisions.

2026-09-03 22:47

Director SIEBEL THOMAS M 🟡 adjusted position in 16.9K shares (1 derivative) of C3.ai, Inc. (AI) at $10.30 Transaction Date: Sep 01, 2026 | Filing ID: 000121

2026-09-02 20:10

(30% Negative) C3.AI, INC. (AI) Reports Q3 2026 Financial Results

2026-09-02 20:05

C3 AI Announces Fiscal First Quarter 2027 Results

2026-08-27 22:35

Director Dwyer John Charles 🟢 acquired 132.1K shares (1 derivative) of C3.ai, Inc. (AI) at $9.79 ($1.3M) Transaction Date: Aug 25, 2026 | Filing ID: 000108

2026-08-27 20:06

(99% Neutral) C3.AI, INC. (AI) Announces New Board Appointment

2026-08-27 19:35

New Form 3 - C3.ai, Inc. Filed: 2026-08-27 AccNo: 0001577526-26-000106 Size: 328 KB

2026-08-20 13:00

C3 AI to Announce Financial Results for Fiscal First Quarter 2027 on September 2, 2026

2026-08-13 21:27

Director SIEBEL THOMAS M 🟡 adjusted position in 453.3K shares (1 derivative) of C3.ai, Inc. (AI) at $10.51 ($8.3M) Transaction Date: Aug 11, 2026 | Filing ID: 000098

2026-08-10 13:00

C3 AI Named Leader in AI Platforms

2026-08-04 23:50

C3 AI Announces New Employee Inducement Grant